Royal Bank Of Canada Sarepta Therapeutics, Inc. Transaction History

Royal Bank Of Canada

  • $458 Billion
  • Q1 2025

A detailed history of Royal Bank Of Canada transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 543,383 shares of SRPT stock, worth $9.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
543,383
Previous 572,697 5.12%
Holding current value
$9.93 Million
Previous $69.6 Million 50.2%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$63.82 - $127.89 $1.87 Million - $3.75 Million
-29,314 Reduced 5.12%
543,383 $34.7 Million
Q4 2024

Feb 14, 2025
SELL
$104.54 - $137.94 $1.39 Million - $1.83 Million
-13,292 Reduced 2.27%
572,697 $69.6 Million
Q3 2024

Nov 14, 2024
BUY
$124.33 - $156.75 $11.2 Million - $14.2 Million
90,449 Added 18.25%
585,989 $73.2 Million
Q2 2024

Aug 14, 2024
BUY
$113.33 - $163.85 $3.96 Million - $5.72 Million
34,934 Added 7.58%
495,540 $78.3 Million
Q1 2024

Nov 05, 2024
SELL
$93.7 - $141.53 $3.27 Million - $4.94 Million
-34,934 Reduced 7.05%
460,606 $59.6 Million
Q1 2024

May 15, 2024
SELL
$93.7 - $141.53 $33.1 Million - $50 Million
-353,423 Reduced 43.42%
460,606 $59.6 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $24.6 Million - $45.6 Million
365,234 Added 81.38%
814,029 $78.5 Million
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $1.65 Million - $1.98 Million
16,051 Added 3.71%
448,795 $54.4 Million
Q2 2023

Aug 14, 2023
BUY
$106.4 - $157.19 $8.03 Million - $11.9 Million
75,504 Added 21.14%
432,744 $49.6 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $6.11 Million - $8.1 Million
51,945 Added 17.01%
357,240 $49.2 Million
Q4 2022

Feb 14, 2023
BUY
$100.86 - $132.13 $21.3 Million - $27.9 Million
211,138 Added 224.24%
305,295 $39.6 Million
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $385,136 - $606,573
-5,087 Reduced 5.13%
94,157 $10.4 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $1.91 Million - $2.7 Million
30,517 Added 44.4%
99,244 $7.44 Million
Q1 2022

May 16, 2022
SELL
$63.15 - $90.42 $307,351 - $440,074
-4,867 Reduced 6.61%
68,727 $5.37 Million
Q4 2021

Feb 14, 2022
SELL
$77.28 - $99.42 $687,869 - $884,937
-8,901 Reduced 10.79%
73,594 $6.63 Million
Q3 2021

Nov 15, 2021
SELL
$65.97 - $92.48 $6.69 Million - $9.38 Million
-101,433 Reduced 55.15%
82,495 $7.63 Million
Q2 2021

Aug 16, 2021
BUY
$69.38 - $86.75 $12.8 Million - $16 Million
183,928 New
183,928 $14.3 Million

Others Institutions Holding SRPT

# of Institutions
467
Shares Held
82.5M
Call Options Held
1.78M
Put Options Held
1.39M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.6B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email